Member Info for Treadstone

Whatever we think here Mr Market seems to be marking the stock down. Bad news leaking out or investors getting impatient..... who knows

Whatever we think here Mr Market seems to be marking the stock down. Bad news leaking out or investors getting impatient..... who knows

Yes and much better buying volume today. Same again tomorrow please...

Hope you are right. Reasonable buying this morning but need a good share price recovery.

Trak holding well so far with all the negativity surrounding world stock markets. Hope this continues.

still nice and stable despite low volumes. Bodes well for 2016.

Wanted to buy this but Hsbc direct unable to deal in this stock. Brilliant I don't think... Any suggestions please..??

Beginning to think I bought a dog here. The market does'nt believe the story here at all.... at least so far.

shorry 'bout dem repeats. mush be tinking in triplicate. i've only had tee martoonies mishter but I'm not as thunk as you drinkle peep. On a more serious note the share price has fallen back to the placing price as I suspected it might after the market had digested the acquisition rns. The placing was over subscribed with new instis coming on board so that should give us confidence. We'll see if the maket starts to stabilise in the coming days. If it continues falling I have cash to add as I believe there's a good growth story here.

while I think about it. Happy Xmas and New Year to all board contributors. Let's hope 2016 will be another year of good growth.

while I think about it. Happy Xmas and New Year to all board contributors. Let's hope 2016 will be another year of good growth.

while I think about it. Happy Xmas and New Year to all board contributors. Let's hope 2016 will be another year of good growth.

to all on this board and let's hope 2016 will be a better year for the share price.

Will be interesting to find out who are our new institutional investors. Good to see placing oversubscribed and not at a heavily discounted price. Might see the sp fall back to 333p whilst Mr Market mulls over the details but hopefully not more. Nice to read that the acquisition will be contributing to revenues almost from the off.

does this share fall on zero trades unless it's featuring on another platform..?? or is this the MMs at work trying to entice some trades to get some activity going..?

You have a good average here and might make your million if company growth goes to plan. agree with everything you say. when you first start buying into an aim stock that you may want to hold it is a bit of a gamble. nobody could have seen the success that was to come at Trak. Fortune favours the brave as they say. I only have a few thousand shares bought at 262p so no fortunes for me. I'm not good at spotting winners. I passed up Asc at 17p back in 2003 and that reached around £70 a few years ago. I made the mistake of asking a stockbroker for advice and he was'nt very enthusiastic. Unless it's a footsie 100 company they know nothing. They like to reach for research notes written by the likes of Seymour Pierce, and if they can't find anything that's it. Just goes to show that for all their pretensions stockbrokers don't know anything more than the average punter. I never heard one warn about a possible collapse in commodity prices, Qpp and Gbo etc. Morgan Stanley warned people to get out of stockmarkets in march 2007. I read that and cashed up for two years. The only piece of good advice I can recall from an institution. When I think of Gbo and how much money some people lost it's not funny. If you can't trust accountant's figures what can you trust. Grant Thornton were the accountants in that case, so I would not be comfortable investing in any company where they are involved. The regulators are far too lax on issues of potential fraud. you have to be on your toes not to be caught out.

Posters on this board have provide useful info so I thought I ought to do the same. If you read the IC which comes out every friday Simon Thompson has been tipping this for a while both in the magazine and online edition. Not all ST's tips come good as the market tends to have its own favourites, but in this case both seem to be of a mind this share looks to be going places based on growing sales, revenues and profits. Cash too..?? As for the AA contracts with 9.5m business to business customers within reach plus more potential contracts to be won elsewhere, the future looks promising. The AA business can only enhance the company's reputation. Lots to look forward to here.

From today's Investors Chronicle - article by Simon Thompson headed Bumper contract win for Trakm8. There seems to be no end in sight to the run of contract wins at telematics and data provider Trakm8 (360p). The company has just announced an extension to its current relationship with the AA. Trakm8 has supplied telematic systems to the AA for its fleet of 3000 roadside assistance and recovery vehicles for the past 4 years, and has recently been working with the organisation to develop a new business- to business fleet management system. The new product will be offered to 9.5m of the AA's buiness-to business customers, enabling them to to help manage the cost and logistics of running their fleets. It is expected to be attractive to large fleet operators as well as SMEs running fleets of five or more vehicles. Executive chairman John Watkins points out that "this is a substantial contract and an extremely interesting opportunity for Trakm8". I wholeheartedly agree and, although analysts have yet to update their profit forecasts, I see obvious upside potential to EPS estimates of 16.5p for the 12 months to end march 17th 2017, up from 11.3p in the current financial year. Moeover if the company continues to win additional contracts, as it has been doing for the past 18 months, then I can only see momentum in the order book and profits building. So having first advised buying Trakm8's shares at 92p ("zoning in on a profitable price move" 16th February 2015), and watched them re-rate by a third since my last update (" patience is paying off" 30th november 2015), Iwould run your 291% pap er profits given the earnings risk is heavily skewed to the upside. Run Profits........End Of. A very favourable report in my opinion and should in itself lend more positive publicity about the company to interested investors. Wish I had bought this long ago.

Interesting links particularly in respect of the pricing issue. big pharma obviously needs a higher price to pay for all the research but there can be a time limit (Boots/ibuprufen) after which cheaper generics made in many parts of the world are allowed in. Since ibuprufen has been cheap for many years, will the market be prepared to pay a higher price for the new oxp version, especially when placed next to the inexpensive stuff on the shelf..?? for those who need to take it to alleviate the additional symptoms it is designed to treat the answer will probably be yes. As for others they will continue to buy the cheap ibuprufen. I'm sure oxp have already looked at all angles when presenting to big pharma, so issues of price, future demand etc must have been carefully examined. Obviously oxp believe the market is ready so all we can do is wait for the outcome of negotiations. As for the demise of the share price investors seem unsure about the outcome. However oxp does have other compounds so its not a one trick pony...

It does look like we're on our way back to 8p... hopefully.